| Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
|---|---|---|---|---|---|---|---|---|
| RNA | AVIDITY BIOSCIENCES INC | 3.17% | 7,266,031 | $206,355,280 | 965,623 | 15.33% | $28.4 | 13F |
| MLYS | Mineralys Therapeutics, Inc. | 2.87% | 7,323,750 | $186,755,625 | 1,176,470 | 19.14% | Form 4 | |
| EWTX | EDGEWISE THERAPEUTICS INC | 1.99% | 9,902,633 | $129,823,519 | 993,542 | 11.15% | $13.11 | 13F |
| SPRY | ARS PHARMACEUTICALS, INC. | 1.81% | 10,940,977 | $106,346,296 | 80,000 | 0.74% | 13D | |
| TYRA | TYRA BIOSCIENCES INC | 1.79% | 12,198,625 | $116,740,841 | 1,561,335 | 14.68% | $9.57 | 13F |
| GHRS | GH RESEARCH PLC | 1.44% | 7,676,697 | $93,578,936 | 732,049 | 10.54% | $12.19 | 13F |
| PEPG | PepGen Inc. | 1.00% | 20,064,545 | $64,206,544 | 9,375,000 | 87.70% | Form 4 | |
| TSHA | TAYSHA GENE THERAPIES INC | 0.84% | 23,555,648 | $54,413,547 | 12,683,145 | 116.65% | $2.31 | 13F |
| SLDB | SOLID BIOSCIENCES INC. | 0.77% | 7,997,510 | $48,304,960 | 2,186,187 | 37.62% | 13D | |
| HOWL | WEREWOLF THERAPEUTICS INC | 0.11% | 6,681,307 | $7,282,625 | 536,426 | 8.73% | $1.09 | 13F |
| CTMX | CYTOMX THERAPEUTICS INC | 0.09% | 2,661,331 | $6,041,221 | 1,661,331 | 166.13% | $2.27 | 13F |